These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6156648)

  • 21. The primary response to LPS and lipid A of P. mirabilis at the cellular level.
    Kotelko K; Gościcka T; Rubinkiewicz H; Szer K; Krajewska D
    Bull Acad Pol Sci Biol; 1975; 23(12):777-83. PubMed ID: 766920
    [No Abstract]   [Full Text] [Related]  

  • 22. Antigenic relationships between pore proteins of Escherichia coli K12.
    Overbeeke N; Van Scharrenburg G; Lugtenberg B
    Eur J Biochem; 1980 Sep; 110(1):247-54. PubMed ID: 7002546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anodically-moving thermolabile antigen (ATA) of gram-negative bacteria: its function as the receptor for F pili.
    Reissbrodt R; Tschäpe H; Seltmann G
    Z Allg Mikrobiol; 1976; 16(1):39-47. PubMed ID: 788356
    [No Abstract]   [Full Text] [Related]  

  • 24. [Protective effect of coli-proteus vaccine in an experimental animal model].
    Bĕlohlávek S; Konícková L
    Cesk Farm; 1980 May; 29(3-4):95-9. PubMed ID: 6996844
    [No Abstract]   [Full Text] [Related]  

  • 25. Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Bouzari S
    APMIS; 2016 Jun; 124(6):444-52. PubMed ID: 26918627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structures of the O-specific polysaccharides and a serological cross-reactivity of the lipopolysaccharides of Proteus mirabilis O24 and O29.
    Literacka E; Perepelov AV; Senchenkova SN; Zatonsky GV; Shashkov AS; Knirel YA; Kaca W
    FEBS Lett; 1999 Aug; 456(2):227-31. PubMed ID: 10456314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection.
    Habibi M; Asadi Karam MR; Bouzari S
    Microb Pathog; 2018 Apr; 117():348-355. PubMed ID: 29452195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotyping of clinical isolates belonging to Proteus mirabilis serogroup O36 and structural elucidation of the O36-antigen polysaccharide.
    Arabski M; Grabowski S; Konieczna I; Kaca W; Kondakova AN; Perepelov AV; Senchenkova SN; Shashkov AS; Knirel YA
    FEMS Immunol Med Microbiol; 2008 Aug; 53(3):395-403. PubMed ID: 18625011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum antibodies against Escherichia coli and Proteus mirabilis after different types of operations.
    Bergman B; Holm SE; Holmlund D; Kaijser B
    Acta Chir Scand; 1981; 147(2):93-7. PubMed ID: 7034429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate immune responses to Proteus mirabilis flagellin in the urinary tract.
    Umpiérrez A; Scavone P; Romanin D; Marqués JM; Chabalgoity JA; Rumbo M; Zunino P
    Microbes Infect; 2013; 15(10-11):688-96. PubMed ID: 23817034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The detection of raised levels of IgM to Proteus mirabilis in sera from patients with rheumatoid arthritis.
    Senior BW; McBride PD; Morley KD; Kerr MA
    J Med Microbiol; 1995 Sep; 43(3):176-84. PubMed ID: 7650724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic and urinary immune response in experimental E. coli pyelonephritis of mice.
    Bluestone R; Goldberg LS; Kalmanson GM; Guze LB
    Int Arch Allergy Appl Immunol; 1973; 45(4):571-81. PubMed ID: 4200918
    [No Abstract]   [Full Text] [Related]  

  • 33. [Possibilities of enhancing the sensitivity of the coagglutination reaction].
    Tishchenko MS
    Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):66-9. PubMed ID: 3898662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homologous and cross-reacting antibodies in the sera of gnotobiotic rats.
    McLeod JC; Balish E
    Can J Microbiol; 1978 Apr; 24(4):365-71. PubMed ID: 346185
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of heat on antigenicity and immunogenicity of the antigenic determinant shared by Haemophilus influenzae type b and Escherichia coli K100.
    Whang HY; Goldhar J; Neter E
    Infect Immun; 1977 Oct; 18(1):68-72. PubMed ID: 71269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of anti-Proteus antibodies in sera of patients with rheumatoid arthritis.
    Gautam V; Sehgal R; Paramjeet SG; Arora DR
    Indian J Pathol Microbiol; 2003 Jan; 46(1):137-41. PubMed ID: 15027757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separate O-grouping schemes for serotyping clinical isolates of Proteus vulgaris and Proteus mirabilis.
    Penner JL; Hennessy JN
    J Clin Microbiol; 1980 Sep; 12(3):304-9. PubMed ID: 7012166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strain differences in the humoral immune response to commensal bacterial antigens in rats.
    Kovačević-Jovanović V; Miletić T; Stanojević S; Mitić K; Dimitrijević M
    Acta Microbiol Immunol Hung; 2013 Sep; 60(3):271-88. PubMed ID: 24060552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein.
    Scavone P; Umpiérrez A; Rial A; Chabalgoity JA; Zunino P
    Antonie Van Leeuwenhoek; 2014 Jun; 105(6):1139-48. PubMed ID: 24771125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.